0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global NK Cell Serum-Free Medium Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-17R19780
Home | Market Reports | Health| Medical Devices & Equipment
Global NK Cell Serum Free Medium Market Research Report 2025
BUY CHAPTERS

Global NK Cell Serum-Free Medium Market Research Report 2025

Code: QYRE-Auto-17R19780
Report
July 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

NK Cell Serum-Free Medium Market Size

The global market for NK Cell Serum-Free Medium was valued at US$ 31.3 million in the year 2024 and is projected to reach a revised size of US$ 41.4 million by 2031, growing at a CAGR of 4.1% during the forecast period.

NK Cell Serum-Free Medium Market

NK Cell Serum-Free Medium Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on NK Cell Serum-Free Medium competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, the global production of NK cell serum-free culture medium will reach 14,612 liters, with an average selling price of US$2,140 per liter. NK cell serum-free medium refers to a medium that does not contain animal serum components and is specifically used to culture NK cells (natural killer cells) in vitro. The purpose of this medium is to provide a more stable, controllable and safer cell culture environment, avoiding the unknown growth factors, hormones, contaminants that may be present in serum, and possible immunogenicity.
North American market for NK Cell Serum-Free Medium is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for NK Cell Serum-Free Medium is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of NK Cell Serum-Free Medium include Fujifilm, Thermo Fisher Scientific, BioLife Solutions, Sartorius, Cytiva, WAK-Chemie Medical, Zenoaq, Merck, Vitrolife Group, Lifeline (ISCO), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for NK Cell Serum-Free Medium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NK Cell Serum-Free Medium.
The NK Cell Serum-Free Medium market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NK Cell Serum-Free Medium market comprehensively. Regional market sizes, concerning products by Type, by Application, b Blood Volume and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NK Cell Serum-Free Medium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, b Blood Volume and by regions.

Scope of NK Cell Serum-Free Medium Market Report

Report Metric Details
Report Name NK Cell Serum-Free Medium Market
Accounted market size in year US$ 31.3 million
Forecasted market size in 2031 US$ 41.4 million
CAGR 4.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Basic Level
  • Research Level
  • Segment b Blood Volume
  • Inoculation Blood Volume: 30ml
  • Inoculation Blood Volume: 50ml
Segment by Application
  • Biotechnology Company
  • Universities and Research Institutes
  • Hospital
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Fujifilm, Thermo Fisher Scientific, BioLife Solutions, Sartorius, Cytiva, WAK-Chemie Medical, Zenoaq, Merck, Vitrolife Group, Lifeline (ISCO), Capricorn, BioLegend, Miltenyi Biotec, CooperSurgical, Yocon Biology, Selcell, Shanghai Epizyme, ExCell Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of NK Cell Serum-Free Medium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of NK Cell Serum-Free Medium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is NK Cell Serum-Free Medium Market growing?

Ans: The NK Cell Serum-Free Medium Market witnessing a CAGR of 4.1% during the forecast period 2025-2031.

What is the NK Cell Serum-Free Medium Market size in 2031?

Ans: The NK Cell Serum-Free Medium Market size in 2031 will be US$ 41.4 million.

Who are the main players in the NK Cell Serum-Free Medium Market report?

Ans: The main players in the NK Cell Serum-Free Medium Market are Fujifilm, Thermo Fisher Scientific, BioLife Solutions, Sartorius, Cytiva, WAK-Chemie Medical, Zenoaq, Merck, Vitrolife Group, Lifeline (ISCO), Capricorn, BioLegend, Miltenyi Biotec, CooperSurgical, Yocon Biology, Selcell, Shanghai Epizyme, ExCell Bio

What are the Application segmentation covered in the NK Cell Serum-Free Medium Market report?

Ans: The Applications covered in the NK Cell Serum-Free Medium Market report are Biotechnology Company, Universities and Research Institutes, Hospital

What are the Type segmentation covered in the NK Cell Serum-Free Medium Market report?

Ans: The Types covered in the NK Cell Serum-Free Medium Market report are Basic Level, Research Level, Segment b Blood Volume, Inoculation Blood Volume: 30ml, Inoculation Blood Volume: 50ml

1 NK Cell Serum-Free Medium Market Overview
1.1 Product Definition
1.2 NK Cell Serum-Free Medium by Type
1.2.1 Global NK Cell Serum-Free Medium Market Value Comparison by Type (2024 VS 2031)
1.2.2 Basic Level
1.2.3 Research Level
1.3 NK Cell Serum-Free Medium b Blood Volume
1.3.1 Global NK Cell Serum-Free Medium Market Value Comparison b Blood Volume: 2024 VS 2031
1.3.2 Inoculation Blood Volume: 30ml
1.3.3 Inoculation Blood Volume: 50ml
1.4 NK Cell Serum-Free Medium by Application
1.4.1 Global NK Cell Serum-Free Medium Market Value by Application (2024 VS 2031)
1.4.2 Biotechnology Company
1.4.3 Universities and Research Institutes
1.4.4 Hospital
1.5 Global NK Cell Serum-Free Medium Market Size Estimates and Forecasts
1.5.1 Global NK Cell Serum-Free Medium Revenue 2020-2031
1.5.2 Global NK Cell Serum-Free Medium Sales 2020-2031
1.5.3 Global NK Cell Serum-Free Medium Market Average Price (2020-2031)
1.6 Assumptions and Limitations
2 NK Cell Serum-Free Medium Market Competition by Manufacturers
2.1 Global NK Cell Serum-Free Medium Sales Market Share by Manufacturers (2020-2025)
2.2 Global NK Cell Serum-Free Medium Revenue Market Share by Manufacturers (2020-2025)
2.3 Global NK Cell Serum-Free Medium Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of NK Cell Serum-Free Medium, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of NK Cell Serum-Free Medium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of NK Cell Serum-Free Medium, Product Type & Application
2.7 Global Key Manufacturers of NK Cell Serum-Free Medium, Date of Enter into This Industry
2.8 Global NK Cell Serum-Free Medium Market Competitive Situation and Trends
2.8.1 Global NK Cell Serum-Free Medium Market Concentration Rate
2.8.2 The Global 5 and 10 Largest NK Cell Serum-Free Medium Players Market Share by Revenue
2.8.3 Global NK Cell Serum-Free Medium Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global NK Cell Serum-Free Medium Market Scenario by Region
3.1 Global NK Cell Serum-Free Medium Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global NK Cell Serum-Free Medium Sales by Region: 2020-2031
3.2.1 Global NK Cell Serum-Free Medium Sales by Region: 2020-2025
3.2.2 Global NK Cell Serum-Free Medium Sales by Region: 2026-2031
3.3 Global NK Cell Serum-Free Medium Revenue by Region: 2020-2031
3.3.1 Global NK Cell Serum-Free Medium Revenue by Region: 2020-2025
3.3.2 Global NK Cell Serum-Free Medium Revenue by Region: 2026-2031
3.4 North America NK Cell Serum-Free Medium Market Facts & Figures by Country
3.4.1 North America NK Cell Serum-Free Medium Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America NK Cell Serum-Free Medium Sales by Country (2020-2031)
3.4.3 North America NK Cell Serum-Free Medium Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe NK Cell Serum-Free Medium Market Facts & Figures by Country
3.5.1 Europe NK Cell Serum-Free Medium Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe NK Cell Serum-Free Medium Sales by Country (2020-2031)
3.5.3 Europe NK Cell Serum-Free Medium Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific NK Cell Serum-Free Medium Market Facts & Figures by Region
3.6.1 Asia Pacific NK Cell Serum-Free Medium Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific NK Cell Serum-Free Medium Sales by Region (2020-2031)
3.6.3 Asia Pacific NK Cell Serum-Free Medium Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America NK Cell Serum-Free Medium Market Facts & Figures by Country
3.7.1 Latin America NK Cell Serum-Free Medium Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America NK Cell Serum-Free Medium Sales by Country (2020-2031)
3.7.3 Latin America NK Cell Serum-Free Medium Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa NK Cell Serum-Free Medium Market Facts & Figures by Country
3.8.1 Middle East and Africa NK Cell Serum-Free Medium Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa NK Cell Serum-Free Medium Sales by Country (2020-2031)
3.8.3 Middle East and Africa NK Cell Serum-Free Medium Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global NK Cell Serum-Free Medium Sales by Type (2020-2031)
4.1.1 Global NK Cell Serum-Free Medium Sales by Type (2020-2025)
4.1.2 Global NK Cell Serum-Free Medium Sales by Type (2026-2031)
4.1.3 Global NK Cell Serum-Free Medium Sales Market Share by Type (2020-2031)
4.2 Global NK Cell Serum-Free Medium Revenue by Type (2020-2031)
4.2.1 Global NK Cell Serum-Free Medium Revenue by Type (2020-2025)
4.2.2 Global NK Cell Serum-Free Medium Revenue by Type (2026-2031)
4.2.3 Global NK Cell Serum-Free Medium Revenue Market Share by Type (2020-2031)
4.3 Global NK Cell Serum-Free Medium Price by Type (2020-2031)
5 Segment by Application
5.1 Global NK Cell Serum-Free Medium Sales by Application (2020-2031)
5.1.1 Global NK Cell Serum-Free Medium Sales by Application (2020-2025)
5.1.2 Global NK Cell Serum-Free Medium Sales by Application (2026-2031)
5.1.3 Global NK Cell Serum-Free Medium Sales Market Share by Application (2020-2031)
5.2 Global NK Cell Serum-Free Medium Revenue by Application (2020-2031)
5.2.1 Global NK Cell Serum-Free Medium Revenue by Application (2020-2025)
5.2.2 Global NK Cell Serum-Free Medium Revenue by Application (2026-2031)
5.2.3 Global NK Cell Serum-Free Medium Revenue Market Share by Application (2020-2031)
5.3 Global NK Cell Serum-Free Medium Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Fujifilm
6.1.1 Fujifilm Company Information
6.1.2 Fujifilm Description and Business Overview
6.1.3 Fujifilm NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Fujifilm NK Cell Serum-Free Medium Product Portfolio
6.1.5 Fujifilm Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Thermo Fisher Scientific NK Cell Serum-Free Medium Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 BioLife Solutions
6.3.1 BioLife Solutions Company Information
6.3.2 BioLife Solutions Description and Business Overview
6.3.3 BioLife Solutions NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BioLife Solutions NK Cell Serum-Free Medium Product Portfolio
6.3.5 BioLife Solutions Recent Developments/Updates
6.4 Sartorius
6.4.1 Sartorius Company Information
6.4.2 Sartorius Description and Business Overview
6.4.3 Sartorius NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sartorius NK Cell Serum-Free Medium Product Portfolio
6.4.5 Sartorius Recent Developments/Updates
6.5 Cytiva
6.5.1 Cytiva Company Information
6.5.2 Cytiva Description and Business Overview
6.5.3 Cytiva NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cytiva NK Cell Serum-Free Medium Product Portfolio
6.5.5 Cytiva Recent Developments/Updates
6.6 WAK-Chemie Medical
6.6.1 WAK-Chemie Medical Company Information
6.6.2 WAK-Chemie Medical Description and Business Overview
6.6.3 WAK-Chemie Medical NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.6.4 WAK-Chemie Medical NK Cell Serum-Free Medium Product Portfolio
6.6.5 WAK-Chemie Medical Recent Developments/Updates
6.7 Zenoaq
6.7.1 Zenoaq Company Information
6.7.2 Zenoaq Description and Business Overview
6.7.3 Zenoaq NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Zenoaq NK Cell Serum-Free Medium Product Portfolio
6.7.5 Zenoaq Recent Developments/Updates
6.8 Merck
6.8.1 Merck Company Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Merck NK Cell Serum-Free Medium Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Vitrolife Group
6.9.1 Vitrolife Group Company Information
6.9.2 Vitrolife Group Description and Business Overview
6.9.3 Vitrolife Group NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Vitrolife Group NK Cell Serum-Free Medium Product Portfolio
6.9.5 Vitrolife Group Recent Developments/Updates
6.10 Lifeline (ISCO)
6.10.1 Lifeline (ISCO) Company Information
6.10.2 Lifeline (ISCO) Description and Business Overview
6.10.3 Lifeline (ISCO) NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Lifeline (ISCO) NK Cell Serum-Free Medium Product Portfolio
6.10.5 Lifeline (ISCO) Recent Developments/Updates
6.11 Capricorn
6.11.1 Capricorn Company Information
6.11.2 Capricorn Description and Business Overview
6.11.3 Capricorn NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Capricorn NK Cell Serum-Free Medium Product Portfolio
6.11.5 Capricorn Recent Developments/Updates
6.12 BioLegend
6.12.1 BioLegend Company Information
6.12.2 BioLegend Description and Business Overview
6.12.3 BioLegend NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BioLegend NK Cell Serum-Free Medium Product Portfolio
6.12.5 BioLegend Recent Developments/Updates
6.13 Miltenyi Biotec
6.13.1 Miltenyi Biotec Company Information
6.13.2 Miltenyi Biotec Description and Business Overview
6.13.3 Miltenyi Biotec NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Miltenyi Biotec NK Cell Serum-Free Medium Product Portfolio
6.13.5 Miltenyi Biotec Recent Developments/Updates
6.14 CooperSurgical
6.14.1 CooperSurgical Company Information
6.14.2 CooperSurgical Description and Business Overview
6.14.3 CooperSurgical NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.14.4 CooperSurgical NK Cell Serum-Free Medium Product Portfolio
6.14.5 CooperSurgical Recent Developments/Updates
6.15 Yocon Biology
6.15.1 Yocon Biology Company Information
6.15.2 Yocon Biology Description and Business Overview
6.15.3 Yocon Biology NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Yocon Biology NK Cell Serum-Free Medium Product Portfolio
6.15.5 Yocon Biology Recent Developments/Updates
6.16 Selcell
6.16.1 Selcell Company Information
6.16.2 Selcell Description and Business Overview
6.16.3 Selcell NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Selcell NK Cell Serum-Free Medium Product Portfolio
6.16.5 Selcell Recent Developments/Updates
6.17 Shanghai Epizyme
6.17.1 Shanghai Epizyme Company Information
6.17.2 Shanghai Epizyme Description and Business Overview
6.17.3 Shanghai Epizyme NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Shanghai Epizyme NK Cell Serum-Free Medium Product Portfolio
6.17.5 Shanghai Epizyme Recent Developments/Updates
6.18 ExCell Bio
6.18.1 ExCell Bio Company Information
6.18.2 ExCell Bio Description and Business Overview
6.18.3 ExCell Bio NK Cell Serum-Free Medium Sales, Revenue and Gross Margin (2020-2025)
6.18.4 ExCell Bio NK Cell Serum-Free Medium Product Portfolio
6.18.5 ExCell Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 NK Cell Serum-Free Medium Industry Chain Analysis
7.2 NK Cell Serum-Free Medium Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 NK Cell Serum-Free Medium Production Mode & Process Analysis
7.4 NK Cell Serum-Free Medium Sales and Marketing
7.4.1 NK Cell Serum-Free Medium Sales Channels
7.4.2 NK Cell Serum-Free Medium Distributors
7.5 NK Cell Serum-Free Medium Customer Analysis
8 NK Cell Serum-Free Medium Market Dynamics
8.1 NK Cell Serum-Free Medium Industry Trends
8.2 NK Cell Serum-Free Medium Market Drivers
8.3 NK Cell Serum-Free Medium Market Challenges
8.4 NK Cell Serum-Free Medium Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global NK Cell Serum-Free Medium Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global NK Cell Serum-Free Medium Market Value b Blood Volume, (US$ Million) & (2024 VS 2031)
 Table 3. Global NK Cell Serum-Free Medium Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 4. Global NK Cell Serum-Free Medium Market Competitive Situation by Manufacturers in 2024
 Table 5. Global NK Cell Serum-Free Medium Sales (L) of Key Manufacturers (2020-2025)
 Table 6. Global NK Cell Serum-Free Medium Sales Market Share by Manufacturers (2020-2025)
 Table 7. Global NK Cell Serum-Free Medium Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 8. Global NK Cell Serum-Free Medium Revenue Share by Manufacturers (2020-2025)
 Table 9. Global Market NK Cell Serum-Free Medium Average Price (US$/L) of Key Manufacturers (2020-2025)
 Table 10. Global Key Players of NK Cell Serum-Free Medium, Industry Ranking, 2022 VS 2023 VS 2024
 Table 11. Global Key Manufacturers of NK Cell Serum-Free Medium, Manufacturing Sites & Headquarters
 Table 12. Global Key Manufacturers of NK Cell Serum-Free Medium, Product Type & Application
 Table 13. Global Key Manufacturers of NK Cell Serum-Free Medium, Date of Enter into This Industry
 Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Global NK Cell Serum-Free Medium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Serum-Free Medium as of 2024)
 Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 17. Global NK Cell Serum-Free Medium Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 18. Global NK Cell Serum-Free Medium Sales by Region (2020-2025) & (L)
 Table 19. Global NK Cell Serum-Free Medium Sales Market Share by Region (2020-2025)
 Table 20. Global NK Cell Serum-Free Medium Sales by Region (2026-2031) & (L)
 Table 21. Global NK Cell Serum-Free Medium Sales Market Share by Region (2026-2031)
 Table 22. Global NK Cell Serum-Free Medium Revenue by Region (2020-2025) & (US$ Million)
 Table 23. Global NK Cell Serum-Free Medium Revenue Market Share by Region (2020-2025)
 Table 24. Global NK Cell Serum-Free Medium Revenue by Region (2026-2031) & (US$ Million)
 Table 25. Global NK Cell Serum-Free Medium Revenue Market Share by Region (2026-2031)
 Table 26. North America NK Cell Serum-Free Medium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 27. North America NK Cell Serum-Free Medium Sales by Country (2020-2025) & (L)
 Table 28. North America NK Cell Serum-Free Medium Sales by Country (2026-2031) & (L)
 Table 29. North America NK Cell Serum-Free Medium Revenue by Country (2020-2025) & (US$ Million)
 Table 30. North America NK Cell Serum-Free Medium Revenue by Country (2026-2031) & (US$ Million)
 Table 31. Europe NK Cell Serum-Free Medium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 32. Europe NK Cell Serum-Free Medium Sales by Country (2020-2025) & (L)
 Table 33. Europe NK Cell Serum-Free Medium Sales by Country (2026-2031) & (L)
 Table 34. Europe NK Cell Serum-Free Medium Revenue by Country (2020-2025) & (US$ Million)
 Table 35. Europe NK Cell Serum-Free Medium Revenue by Country (2026-2031) & (US$ Million)
 Table 36. Asia Pacific NK Cell Serum-Free Medium Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 37. Asia Pacific NK Cell Serum-Free Medium Sales by Region (2020-2025) & (L)
 Table 38. Asia Pacific NK Cell Serum-Free Medium Sales by Region (2026-2031) & (L)
 Table 39. Asia Pacific NK Cell Serum-Free Medium Revenue by Region (2020-2025) & (US$ Million)
 Table 40. Asia Pacific NK Cell Serum-Free Medium Revenue by Region (2026-2031) & (US$ Million)
 Table 41. Latin America NK Cell Serum-Free Medium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 42. Latin America NK Cell Serum-Free Medium Sales by Country (2020-2025) & (L)
 Table 43. Latin America NK Cell Serum-Free Medium Sales by Country (2026-2031) & (L)
 Table 44. Latin America NK Cell Serum-Free Medium Revenue by Country (2020-2025) & (US$ Million)
 Table 45. Latin America NK Cell Serum-Free Medium Revenue by Country (2026-2031) & (US$ Million)
 Table 46. Middle East and Africa NK Cell Serum-Free Medium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 47. Middle East and Africa NK Cell Serum-Free Medium Sales by Country (2020-2025) & (L)
 Table 48. Middle East and Africa NK Cell Serum-Free Medium Sales by Country (2026-2031) & (L)
 Table 49. Middle East and Africa NK Cell Serum-Free Medium Revenue by Country (2020-2025) & (US$ Million)
 Table 50. Middle East and Africa NK Cell Serum-Free Medium Revenue by Country (2026-2031) & (US$ Million)
 Table 51. Global NK Cell Serum-Free Medium Sales (L) by Type (2020-2025)
 Table 52. Global NK Cell Serum-Free Medium Sales (L) by Type (2026-2031)
 Table 53. Global NK Cell Serum-Free Medium Sales Market Share by Type (2020-2025)
 Table 54. Global NK Cell Serum-Free Medium Sales Market Share by Type (2026-2031)
 Table 55. Global NK Cell Serum-Free Medium Revenue (US$ Million) by Type (2020-2025)
 Table 56. Global NK Cell Serum-Free Medium Revenue (US$ Million) by Type (2026-2031)
 Table 57. Global NK Cell Serum-Free Medium Revenue Market Share by Type (2020-2025)
 Table 58. Global NK Cell Serum-Free Medium Revenue Market Share by Type (2026-2031)
 Table 59. Global NK Cell Serum-Free Medium Price (US$/L) by Type (2020-2025)
 Table 60. Global NK Cell Serum-Free Medium Price (US$/L) by Type (2026-2031)
 Table 61. Global NK Cell Serum-Free Medium Sales (L) by Application (2020-2025)
 Table 62. Global NK Cell Serum-Free Medium Sales (L) by Application (2026-2031)
 Table 63. Global NK Cell Serum-Free Medium Sales Market Share by Application (2020-2025)
 Table 64. Global NK Cell Serum-Free Medium Sales Market Share by Application (2026-2031)
 Table 65. Global NK Cell Serum-Free Medium Revenue (US$ Million) by Application (2020-2025)
 Table 66. Global NK Cell Serum-Free Medium Revenue (US$ Million) by Application (2026-2031)
 Table 67. Global NK Cell Serum-Free Medium Revenue Market Share by Application (2020-2025)
 Table 68. Global NK Cell Serum-Free Medium Revenue Market Share by Application (2026-2031)
 Table 69. Global NK Cell Serum-Free Medium Price (US$/L) by Application (2020-2025)
 Table 70. Global NK Cell Serum-Free Medium Price (US$/L) by Application (2026-2031)
 Table 71. Fujifilm Company Information
 Table 72. Fujifilm Description and Business Overview
 Table 73. Fujifilm NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 74. Fujifilm NK Cell Serum-Free Medium Product
 Table 75. Fujifilm Recent Developments/Updates
 Table 76. Thermo Fisher Scientific Company Information
 Table 77. Thermo Fisher Scientific Description and Business Overview
 Table 78. Thermo Fisher Scientific NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 79. Thermo Fisher Scientific NK Cell Serum-Free Medium Product
 Table 80. Thermo Fisher Scientific Recent Developments/Updates
 Table 81. BioLife Solutions Company Information
 Table 82. BioLife Solutions Description and Business Overview
 Table 83. BioLife Solutions NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 84. BioLife Solutions NK Cell Serum-Free Medium Product
 Table 85. BioLife Solutions Recent Developments/Updates
 Table 86. Sartorius Company Information
 Table 87. Sartorius Description and Business Overview
 Table 88. Sartorius NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 89. Sartorius NK Cell Serum-Free Medium Product
 Table 90. Sartorius Recent Developments/Updates
 Table 91. Cytiva Company Information
 Table 92. Cytiva Description and Business Overview
 Table 93. Cytiva NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 94. Cytiva NK Cell Serum-Free Medium Product
 Table 95. Cytiva Recent Developments/Updates
 Table 96. WAK-Chemie Medical Company Information
 Table 97. WAK-Chemie Medical Description and Business Overview
 Table 98. WAK-Chemie Medical NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 99. WAK-Chemie Medical NK Cell Serum-Free Medium Product
 Table 100. WAK-Chemie Medical Recent Developments/Updates
 Table 101. Zenoaq Company Information
 Table 102. Zenoaq Description and Business Overview
 Table 103. Zenoaq NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 104. Zenoaq NK Cell Serum-Free Medium Product
 Table 105. Zenoaq Recent Developments/Updates
 Table 106. Merck Company Information
 Table 107. Merck Description and Business Overview
 Table 108. Merck NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 109. Merck NK Cell Serum-Free Medium Product
 Table 110. Merck Recent Developments/Updates
 Table 111. Vitrolife Group Company Information
 Table 112. Vitrolife Group Description and Business Overview
 Table 113. Vitrolife Group NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 114. Vitrolife Group NK Cell Serum-Free Medium Product
 Table 115. Vitrolife Group Recent Developments/Updates
 Table 116. Lifeline (ISCO) Company Information
 Table 117. Lifeline (ISCO) Description and Business Overview
 Table 118. Lifeline (ISCO) NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 119. Lifeline (ISCO) NK Cell Serum-Free Medium Product
 Table 120. Lifeline (ISCO) Recent Developments/Updates
 Table 121. Capricorn Company Information
 Table 122. Capricorn Description and Business Overview
 Table 123. Capricorn NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 124. Capricorn NK Cell Serum-Free Medium Product
 Table 125. Capricorn Recent Developments/Updates
 Table 126. BioLegend Company Information
 Table 127. BioLegend Description and Business Overview
 Table 128. BioLegend NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 129. BioLegend NK Cell Serum-Free Medium Product
 Table 130. BioLegend Recent Developments/Updates
 Table 131. Miltenyi Biotec Company Information
 Table 132. Miltenyi Biotec Description and Business Overview
 Table 133. Miltenyi Biotec NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 134. Miltenyi Biotec NK Cell Serum-Free Medium Product
 Table 135. Miltenyi Biotec Recent Developments/Updates
 Table 136. CooperSurgical Company Information
 Table 137. CooperSurgical Description and Business Overview
 Table 138. CooperSurgical NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 139. CooperSurgical NK Cell Serum-Free Medium Product
 Table 140. CooperSurgical Recent Developments/Updates
 Table 141. Yocon Biology Company Information
 Table 142. Yocon Biology Description and Business Overview
 Table 143. Yocon Biology NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 144. Yocon Biology NK Cell Serum-Free Medium Product
 Table 145. Yocon Biology Recent Developments/Updates
 Table 146. Selcell Company Information
 Table 147. Selcell Description and Business Overview
 Table 148. Selcell NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 149. Selcell NK Cell Serum-Free Medium Product
 Table 150. Selcell Recent Developments/Updates
 Table 151. Shanghai Epizyme Company Information
 Table 152. Shanghai Epizyme Description and Business Overview
 Table 153. Shanghai Epizyme NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 154. Shanghai Epizyme NK Cell Serum-Free Medium Product
 Table 155. Shanghai Epizyme Recent Developments/Updates
 Table 156. ExCell Bio Company Information
 Table 157. ExCell Bio Description and Business Overview
 Table 158. ExCell Bio NK Cell Serum-Free Medium Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 159. ExCell Bio NK Cell Serum-Free Medium Product
 Table 160. ExCell Bio Recent Developments/Updates
 Table 161. Key Raw Materials Lists
 Table 162. Raw Materials Key Suppliers Lists
 Table 163. NK Cell Serum-Free Medium Distributors List
 Table 164. NK Cell Serum-Free Medium Customers List
 Table 165. NK Cell Serum-Free Medium Market Trends
 Table 166. NK Cell Serum-Free Medium Market Drivers
 Table 167. NK Cell Serum-Free Medium Market Challenges
 Table 168. NK Cell Serum-Free Medium Market Restraints
 Table 169. Research Programs/Design for This Report
 Table 170. Key Data Information from Secondary Sources
 Table 171. Key Data Information from Primary Sources
 Table 172. Authors List of This Report


List of Figures
 Figure 1. Product Picture of NK Cell Serum-Free Medium
 Figure 2. Global NK Cell Serum-Free Medium Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global NK Cell Serum-Free Medium Market Share by Type: 2024 & 2031
 Figure 4. Basic Level Product Picture
 Figure 5. Research Level Product Picture
 Figure 6. Global NK Cell Serum-Free Medium Market Value b Blood Volume, (US$ Million) & (2020-2031)
 Figure 7. Global NK Cell Serum-Free Medium Market Share b Blood Volume: 2024 VS 2031
 Figure 8. Inoculation Blood Volume: 30ml Product Picture
 Figure 9. Inoculation Blood Volume: 50ml Product Picture
 Figure 10. Global NK Cell Serum-Free Medium Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global NK Cell Serum-Free Medium Market Share by Application: 2024 & 2031
 Figure 12. Biotechnology Company
 Figure 13. Universities and Research Institutes
 Figure 14. Hospital
 Figure 15. Global NK Cell Serum-Free Medium Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global NK Cell Serum-Free Medium Market Size (2020-2031) & (US$ Million)
 Figure 17. Global NK Cell Serum-Free Medium Sales (2020-2031) & (L)
 Figure 18. Global NK Cell Serum-Free Medium Average Price (US$/L) & (2020-2031)
 Figure 19. NK Cell Serum-Free Medium Report Years Considered
 Figure 20. NK Cell Serum-Free Medium Sales Share by Manufacturers in 2024
 Figure 21. Global NK Cell Serum-Free Medium Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest NK Cell Serum-Free Medium Players: Market Share by Revenue in NK Cell Serum-Free Medium in 2024
 Figure 23. NK Cell Serum-Free Medium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global NK Cell Serum-Free Medium Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America NK Cell Serum-Free Medium Sales Market Share by Country (2020-2031)
 Figure 26. North America NK Cell Serum-Free Medium Revenue Market Share by Country (2020-2031)
 Figure 27. United States NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe NK Cell Serum-Free Medium Sales Market Share by Country (2020-2031)
 Figure 30. Europe NK Cell Serum-Free Medium Revenue Market Share by Country (2020-2031)
 Figure 31. Germany NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific NK Cell Serum-Free Medium Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific NK Cell Serum-Free Medium Revenue Market Share by Region (2020-2031)
 Figure 38. China NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America NK Cell Serum-Free Medium Sales Market Share by Country (2020-2031)
 Figure 46. Latin America NK Cell Serum-Free Medium Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Colombia NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa NK Cell Serum-Free Medium Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa NK Cell Serum-Free Medium Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE NK Cell Serum-Free Medium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of NK Cell Serum-Free Medium by Type (2020-2031)
 Figure 57. Global Revenue Market Share of NK Cell Serum-Free Medium by Type (2020-2031)
 Figure 58. Global NK Cell Serum-Free Medium Price (US$/L) by Type (2020-2031)
 Figure 59. Global Sales Market Share of NK Cell Serum-Free Medium by Application (2020-2031)
 Figure 60. Global Revenue Market Share of NK Cell Serum-Free Medium by Application (2020-2031)
 Figure 61. Global NK Cell Serum-Free Medium Price (US$/L) by Application (2020-2031)
 Figure 62. NK Cell Serum-Free Medium Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart